IMPERIAL OIL LTD (IMO)       49.87  -0.5 (-0.99%)

49.87  -0.5 (-0.99%)

CA4530384086 - Common Stock


Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to IMO. IMO was compared to 391 industry peers in the Oil, Gas & Consumable Fuels industry. While IMO has a great health rating, its profitability is only average at the moment. IMO has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!




Profitability

Profitability Rating

6

IMO's Return On Assets of 14.95% is amongst the best of the industry. IMO does better than the industry average Return On Assets of 12.18%.
IMO has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for IMO.

IMO's Return On Equity of 28.81% is in line with the rest of the industry. The industry average Return On Equity is 26.95%.
IMO has a Profit Margin of 11.21%. This is below the industry average of 25.51%.
VS Industry

ROA (14.95%) VS Industry: 61% outperformed.

0.06
1,189.87

ROE (28.81%) VS Industry: 54% outperformed.

0.24
5,310.48

Profit Margin (11.21%) VS Industry: 26% outperformed.

0.07
268.29

Valuation

Valuation Rating

7

With a Price/Earnings Ratio of 6.68, the valuation of IMO can be described as very cheap.
With a Forward Price/Earnings Ratio of 6.61, the valuation of IMO can be described as cheap.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMO's Price/Earning Ratio is in line with the industry average which is at 6.40.

When comparing the current price to the book value of IMO, we can conclude it is valued correctly. It is trading at 1.75 times its book value.
Compared to an average industry price book ratio of 1.57, IMO is valued in line with its industry peers.
When comparing the Enterprise Value to EBITDA ratio of IMO to the average industry ratio of 4.04, IMO is valued in line with its industry peers.
VS Industry

Price/Earnings (6.68) VS Industry: 47% outperformed.

1,200.00
0.06

Price/Book (1.75) VS Industry: 42% outperformed.

3,337.66
0.04

Enterprise Value/ EBITDA (3.94) VS Industry: 50% outperformed.

242.49
0.24

Growth

Growth Rating

9

The Earnings Per Share has grown by an impressive 324.26% over the past year.
The Earnings Per Share has been growing by 48.39% on average over the past 5 years. This is a very strong growth
IMO is expected to show a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 38.35% yearly.
The Revenue has grown by 83.50% in the past year. This is a very strong growth!

The Revenue is expected to grow by 24.18% on average over the next 5 years. This is a very strong growth
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The EPS growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.
The Revenue has been growing slightly by 8.07% on average over the past 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS48.39% 7.92% 324.26% 204.97% 65.8% 38.35% N/A
Revenue8.07% 2.37% 83.5% 70.66% 38.22% 24.18% N/A

Health

Health Rating

7

IMO has an Altman-Z score of 3.88. This indicates that IMO is financially healthy and little risk of bankruptcy at the moment.
IMO is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 2.13.
IMO has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for IMO.
A Current Ratio of 1.23 indicates that IMO should not have too much problems paying its short term obligations.

IMO has a Current Ratio comparable to the industry average, which is at 1.11.
IMO has a Quick Ratio of 1.06. This is a normal value and indicates that IMO is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 0.95.
The Debt to Equity ratio of IMO is in line with the industry averages.
VS Industry

Debt/Equity (0.18) VS Industry: 56% outperformed.

31.33
0.00

Quick Ratio (1.06) VS Industry: 55% outperformed.

0.00
297.28

Current Ratio (1.23) VS Industry: 54% outperformed.

0.00
297.28

Altman-Z (3.88) VS Industry: 73% outperformed.

-283,883.15
1,024.97

Dividend

Dividend Rating

6

The dividend of IMO is nicely growing with an annual growth rate of 11.87%!
IMO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
IMO pays out 12.89% of its income as dividend. This is a sustainable payout ratio.
IMO has been paying a dividend for at least 10 years, so it has a reliable track record.

IMO has a Yearly Dividend Yield of 2.58%. Purely for dividend investing, there may be better candidates out there.
IMO's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Compared to an average industry Dividend Yield of 5.56, IMO is paying slightly less dividend.
VS Industry

Dividend Yield (2.58%) VS Industry: 23% outperformed.

0.34
64.51

IMPERIAL OIL LTD49.87

NYSEARCA:IMO (2/6/2023, 1:52:07 PM)-0.5 (-0.99%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 01-30 2023-01-30/amc Earnings (Next) 04-27 2023-04-27/amc
Inst Owners 21.46% Inst Owner Change 2.4%
Ins Owners N/A Ins Owner Change N/A
Market Cap 29.13B Analysts 67.27
Price Target 60.36 (21.03%)

Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Dividend Growth(5Y) 11.87% DP 12.89%
Div Incr Years 5 Div Non Decr Years 5
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 29.6%
Min EPS beat(2) 17.81% Max EPS beat(2) 41.39%
EPS beat(4) 2 Avg EPS beat(4) 12.76%
Min EPS beat(4) -5.45% Max EPS beat(4) 41.39%
Revenue beat(2) N/A Avg Revenue beat(2) -27.39%
Min Revenue beat(2) -34.07% Max Revenue beat(2) -20.7%
Revenue beat(4) 1 Avg Revenue beat(4) -13.52%
Min Revenue beat(4) -34.07% Max Revenue beat(4) 8.07%
PT rev (1m) 1.85% PT rev (3m) 6.96%
EPS NQ rev (1m) 3.27% EPS NQ rev (3m) 9.75%
EPS NY rev (1m) 0% EPS NY rev (3m) -0.29%
Revenue NQ rev (1m) 1.32% Revenue NQ rev (3m) -6.29%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -7.28%

Valuation
Industry RankSector Rank
PE 6.68
Fwd PE 6.61
P/S 0.68
P/FCF 4.95
P/OCF 4.18
P/B 1.75
P/tB 1.76
EV/EBITDA 3.94
EPS(TTM) 7.46 EY 14.96%
EPS(NY) 7.55 Fwd EY 15.14%
FCF(TTM) 10.07 FCFY 20.19%
OCF(TTM) 11.93 OCFY 23.93%
SpS 73.41 BVpS 28.58
TBVpS 28.36 PEG (NY) 0.03
PEG (5Y) 0.14

Profitability
Industry RankSector Rank
ROA 14.95%
ROE 28.81%
ROIC 18.07%
ROICexc 20.2%
ROICexgc 20.31%
OM 14.22%
PM 11.21%
GM 22.97%
ROICexgc(3y) N/A ROICexcg growth 3Y 5.66%
ROICexcg growth 5Y 43.67% ROICexc(3y) N/A
ROICexc growth 3Y 5.66% ROICexc growth 5Y 43.67%
OM growth 3Y -0.13% OM growth 5Y 29.73%
PM growth 3Y -0.05% PM growth 5Y -4.93%
GM growth 3Y 0.78% GM growth 5Y 1.29%
F-Score 8 Asset Turnover 1.33

Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 0.53
Debt/EBITDA 0.41
Cap/Depr 73.75%
Profit Quality 122.3%
Current Ratio 1.23
Quick Ratio 1.06
Altman-Z 3.88
F-Score 8 WACC 11.57%
ROIC/WACC 1.75 Cap/Depr(3y) 61.65%
Cap/Depr(5y) 65.89% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 324.26% EPS 3Y 7.92%
EPS 5Y 48.39% EPS growth Q2Q 151.16%
EPS Next Y 204.97% EPS Next 2Y 65.8%
EPS Next 3Y 38.35% EPS Next 5Y N/A
Revenue growth 1Y 83.5% Revenue growth 3Y 2.37%
Revenue growth 5Y 8.07% Revenue growth Q2Q 47.55%
Revenue Next Year 70.66% Revenue Next 2Y 38.22%
Revenue Next 3Y 24.18% Revenue Next 5Y N/A
EBIT growth 1Y 274.93% EBIT growth 3Y 2.24%
EBIT growth 5Y 40.2% EBIT Next Year 240.05%
EBIT Next 3Y 33.65% EBIT Next 5Y N/A
FCF growth 1Y 1627.25% FCF growth 3Y 21.57%
FCF growth 5Y 35.91% OCF growth 1Y 518.66%
OCF growth 3Y 11.77% OCF growth 5Y 22.13%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA